Skip to content

Form 4 filed by Torley Helen

Torley Helen filed this Form 4 on HALO (HALOZYME THERAPEUTICS, INC.) with 18 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-17 01:33:59 UTC.

Accession
0001159036-26-000147
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: HALO · HALOZYME THERAPEUTICS, INC. (CIK 1159036)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-12M exercised+20,000$18.41787,780D
Common Stock 2026-11-12S sold-10,711$101.093777,069D
Common Stock 2026-11-12S sold-9,289$101.494767,780D
Common Stock 2026-11-13M exercised+1,552$18.41769,332D
Common Stock 2026-11-13M exercised+18,448$16.65787,780D
Common Stock 2026-11-13S sold-7,992$100.019779,788D
Common Stock 2026-11-13S sold-12,008$100.614767,780D
Common Stock 2026-11-16M exercised+20,000$16.65787,780D
Common Stock 2026-11-16S sold-7,283$96.848780,497D
Common Stock 2026-11-16S sold-4,802$97.955775,695D
Common Stock 2026-11-16S sold-1,586$98.891774,109D
Common Stock 2026-11-16S sold-4,897$100.096769,212D
Common Stock 2026-11-16S sold-1,244$101.059767,968D
Common Stock 2026-11-16S sold-188$101.72767,780D
Option to Purchase Common Stock derivative2026-11-12M exercised-20,000$18.411,552D
Option to Purchase Common Stock derivative2026-11-13M exercised-1,552$18.410D
Option to Purchase Common Stock derivative2026-11-13M exercised-18,448$16.65231,770D
Option to Purchase Common Stock derivative2026-11-16M exercised-20,000$16.65211,770D